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Pulmonary and systemic arterial hypertension are associated with profound alterations in Ca2+ homeostasis and smooth muscle cell
proliferation. A novel class of non-selective cation channels, the transient receptor potential (TRP) channels, have emerged at the forefront of
research into hypertensive disease states. TRP channels are identified as molecular correlates for receptor-operated and store-operated cation
channels in the vasculature. Over 10 TRP isoforms are identified at the mRNA and protein expression levels in the vasculature. Current research
implicates upregulation of specific TRP isoforms to be associated with increased Ca2+ influx, characteristic of vasoconstriction and vascular
smooth muscle cell proliferation. TRP channels are implicated as Ca2+ entry pathways in pulmonary hypertension and essential hypertension.
Caveolae have recently emerged as membrane microdomains in which TRP channels may be co-localized with the endoplasmic reticulum in both
smooth muscle and endothelial cells. Such enhanced expression and function of TRP channels and their localization in caveolae in
pathophysiological hypertensive disease states highlights their importance as potential targets for pharmacological intervention.
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hypertension
In all vascular beds, precise regulation of circulatory hemo-
dynamics is predominantly controlled by the cardiac output and
vascular resistance. The pulmonary circulation, being a high
flow, low-pressure system, has less than one tenth of the flow
resistance observed in the high-pressure systemic vasculature.
Essential hypertension (or primary systemic arterial hyper-
tension) is characterized by a sustained blood pressure over 140/
90 mm Hg. In the early stages of the disease, cardiac output is
increased although total peripheral resistance remains constant;Abbreviations: CCE, capacitative Ca2+ entry; EC, endothelial cell; NCX,
Na+–Ca2+ exchanger; PAEC, pulmonary artery endothelial cell; PAH,
pulmonary arterial hypertension; PASMC, pulmonary artery smooth muscle
cell; ROC, receptor-operated Ca2+ channel; SERCA, sarcoplasmic/endoplasmic
reticulum Ca2+-ATPase; SMC, smooth muscle cell; SOC, store-operated Ca2+
channel; SR, sarcoplasmic reticulum; TRP, transient receptor potential channel
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doi:10.1016/j.bbadis.2007.02.009cardiac output drops when the disease is sustained and total
peripheral resistance is elevated, with changes in peripheral
resistance mainly reflecting the degree of arterial tone. Over
90% of all cases of adult systemic arterial hypertension have no
clear cause and are therefore referred to as essential or primary
hypertension.
Pulmonary arterial hypertension (PAH) develops when the
mean pulmonary artery pressure is sustained at an elevated level =
25 mm Hg at rest or 30 mm Hg during exercise and is
associated with a progressive and sustained increase in
pulmonary vascular resistance. Most of the patients with PAH
have normal cardiac output, indicating that increased pulmonary
vascular resistance is the major cause for the elevated pul-
monary artery pressure in these patients. PAH is characterized
by progressive pulmonary vasculopathy which, if left untreated,
leads to right heart failure with poor prognosis. Increased
pulmonary vascular resistance in PAH patients may be caused
by sustained pulmonary vasoconstriction and considerable
obstruction of the lumen of small arteries caused primarily by
excessive proliferation of pulmonary artery smooth muscle cells
(PASMC) in the vascular wall.
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tension, the two predominant forms of PAH are currently
classified as idiopathic and familial PAH. Idiopathic PAH is
rare, principally affecting women, and its underlying cause
remains undetermined. Familial PAH represents hereditary
communication of PAH and is thought to be the cause of 6–10%
of PAH cases. Familial PAH is genetically predicted where
successive family generations develop PAH. Pulmonary vas-
cular intimal and medial hypertrophy is the characterizing
feature of idiopathic and familial PAH.
The pulmonary circulation is essential to the maintenance of
sufficient circulating O2 levels. When alveolar O2 levels are
compromised or partial pressure of O2 is lower than 60 mm Hg,
it responds uniquely by constricting pulmonary arteries and
diverting blood flow to the well-ventilated areas in the lung to
ensure maximal oxygenation of the venous blood by adequately
matching ventilation with perfusion. The alveolar hypoxia-
mediated vasoconstrictive phenomenon is known as hypoxic
pulmonary vasoconstriction. Vasoconstriction may also be
triggered by a number of receptor-activated mechanisms
involving endothelin-1 (ET-1) acting on ETA and ETB receptors
[1], angiotensin II acting on AT1 receptors [2], and endoper-
oxides diffusing from endothelial cells acting on smooth muscle
cell (SMC) TP-receptors [3]. Sustained pulmonary vasocon-
striction is often accompanied by vascular remodelling, i.e., the
muscularization of smaller arteries and arterioles due to SMC
proliferation and migration. In severe forms of pulmonary
hypertension (such as idiopathic and familial PAH), pulmonary
artery remodelling is extensive resulting from intimal fibrosis
and medial hypertrophy. Such occlusion of the pulmonary
arterioles is associated with the formation of plexiform lesions
resultant of the proliferation of endothelial cells, migration and
proliferation of SMC, and accumulation of circulating cells
(including macrophages and endothelial progenitor cells).
In both pulmonary and systemic circulation, the blood flow
and intraluminal pressure are mainly regulated by changes in
vessel diameter (or radius). The contractility and proliferation of
smooth muscle is reliant upon increases in intracellular Ca2+
concentration ([Ca2+]i). The fundamental systems coordinating
changes in [Ca2+]i are: (a) Ca
2+ entry via voltage-dependent Ca2+
channels, receptor-operated cation channels (ROC), and/or store-
operated channels (SOC); (b) Ca2+ release and sequestration from
and into the sarcoplasmic (SR) or endoplasmic (ER) reticulum;
(c) Ca2+ extrusion to the extracellular space by Ca2+–Mg2+
ATPase pumps; (d) outward transportation of Ca2+ by the forward
mode of Na+–Ca2+ exchangers (NCX) and inward transportation
of Ca2+ by the reverse mode of NCX; (e) mitochondrial Ca2+
release and sequestration; and (f) release and sequestration from
and into other intracellular Ca2+ stores (e.g., lysosomes).
The precise molecular entity of ROC and SOC, in particular,
remained indefinable until recently. It is now believed that
transient receptor potential channels (TRPs) participate in the
formation of functional ROC and SOC in the vasculature. TRP
channels have emerged at the forefront of research in the
physiological and pathophysiological regulation of the vascu-
lature having awide tissue distribution and diversity of functions.
This review examines the current state of knowledge of TRPexpression and function in the vasculature, and the potentially
pivotal pathophysiological changes in the expression of TRP
channels associated with both pulmonary and essential hyperten-
sion. Both essential and pulmonary hypertension can lead to
cardiac hypertrophy, which itself is also highly dependent on the
expression and function of TRP-encoded cation channels. The
role of TRPs in cardiac function is not discussed in the review, but
readers are invited to peruse related articles for more information
[4–8].
2. Transient receptor potential channels (TRP)
TRP channels belong to the superfamily of cation channels
formed by tetramers of six transmembrane domain subunits
which enclose a pore near the C-terminal end [9] (Fig. 1).
Unlike voltage-gated ion (Ca2+ and K+) channels, TRP subunits
do not possess a voltage-sensing moiety, making their activity
insensitive to changes in membrane potential. TRP channels
therefore function as voltage-independent, non-selective cation
channels which are permeable to Na+, K+, Cs+, Li+, Ca2+, and
Mg2+ [10]. TRP subunits are split into several subfamilies
according to their activation stimuli and the presence of
regulatory domains on the cytosolic N- and C-termini (Fig.
1). Canonical TRP (TRPC) is activated by G protein-coupled
receptors and receptor tyrosine kinases linked to phosphoinosi-
tide hydrolysis via phospholipase C (PLC) activation [11,12]
(Fig. 2). A variety of chemical and physical stimuli including
capsaicin, lipids, acid, heat, shear stress, and hypoosmolarity
can activate vanilloid receptor related TRP (TRPV). Melastatin
related TRP (TRPM) [11] are either constitutively active or
activated in response to increased [Ca2+]i, oxidative stress, or
exposure to the cold. Less distinctly related families associated
with specific genetic disorders, include the polycystins (TRPP),
mucolipidins (TRPML), mechanoreceptor potential C (TRPN),
and ankyrin (TRPA) [11] TRP subfamilies.
3. Expression pattern and regulation of TRPs in the
vasculature
In vascular smooth muscle cells more than ten TRP isoforms
have been detected (Table 1). Their expression patterns in
vascular myocytes (both smooth muscle and endothelial) are
discussed further below.
3.1. TRPC
TRPC1 is broadly expressed throughout the vasculature
[13,14] and is linked to Ca2+ entry associated with intracellular
(i.e., SR) store depletion by agonists, inhibitors of SR Ca2+-
ATPase (SERCA) pumps, or strong Ca2+ buffering. SOC-
mediated Ca2+ influx triggered by SR Ca2+ depletion is termed
capacitative Ca2+ entry (CCE). Evidence currently favours the
proposal that TRPC1 is one of the pore-forming subunits of SOC
in vascular myocytes [13,15,16] and that TRPC1 is a key
isoform responsible for CCE-induced pulmonary vasoconstric-
tion and proliferation [14,17,18]. The use of siRNA and
antisense technology has reinforced the proposal that TRPC1
Fig. 1. Structure of TRP Channels. (A) Representative topological structure of
TRPC1, TRPV1, TRPM7, and TRPP (PKD2). Six transmembrane domains
(TM1–TM6), ankyrin repeats or ankyrin-like domains (A), pore region (P), TRP
box, caveolin-scaffolding (CSD) and coiled-coil (CC) domains are shown. (B)
Subunit arrangement of TRP monomers into functional homo- or hetero-
tetrameric channels with a central ion-conducting pore.
Fig. 2. Receptor-mediated increase in [Ca2+]cyt in pulmonary artery smooth
muscle cells (PASMC). (A) Upon activation of membrane receptors including G
protein-coupled receptors (GPCR) and receptor tyrosine kinases (RTK) by
ligands, store-operated cation channels (SOC) are activated by store depletion as
a result of IP3-mediated Ca
2+ mobilization from the sarcoplasmic reticulum (SR).
(B) Receptor-operated cation channels (ROC) are activated by diacylglycerol and
PKC activation. Opening of SOC and ROC not only causes Ca2+ influx, but also
Na+ influx. The increased cytoplasmic [Na+] in close proximity to the Na+/Ca2+
exchanger (NCX) activates the reverse mode of NCX and promotes inward Ca2+
transport. Increased cytosolic Ca2+ concentration ([Ca2+]cyt) is a major trigger for
PASMC contraction, proliferation and migration.
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TRPC1 is likely to form heteromultimeric channels (Fig. 1B),
possibly with TRPC4, TRPC5, TRPC3 and TRPP2 subunits in
vascular tissues [20]. Such interactions with other TRPC
isoforms could be crucial in the trafficking or translocation of
TRPC1 to the plasma membrane, as demonstrated in TRPC1–
TRPC4 co-expression studies [9].
TRPC6 is also ubiquitously expressed amongst the vascular
tissues and belongs to the diacylglycerol-activated ROC family
(along with TRPC 3 and TRPC7) [21]. ROC differs from SOC in
that its activation requires receptor binding to trigger the PLC-
coupled cascade. TRPC6 mRNA and protein have been widelydetected in isolated systemic [19,22–27] and pulmonary arterial
SMC [28–31]. Vascular contractility was increased in TRPC6
knock-out mice [32], suggesting that TRPC6 is involved in
regulating vascular tone. In a recent study, Weissman et al.
demonstrated a role for TRPC6 in the contractile response of
pulmonary arteries in response to acute hypoxia [33]. Selective
knock-out of the TRPC6 gene (TRPC6−/−) abolished hypoxic
pulmonary vasoconstriction, and hypoxia-induced cation influx
in isolated PASMC. Furthermore, there was a significant
accumulation of diacylglycerol in TRPC6−/− mouse PASMC,
further reinforcing the suggestion that TRPC6 belongs to the
ROC family of Ca2+ channels.
In the study by Dietrich et al. [32], TRPC3 expression was
enhanced in TRPC6−/− mice; however, TRPC3 upregulation
was not functionally interchangeable with TRPC6 [32].Whether
TRPC3 functions as a SOC [34,35] or ROC [36,37] is debatable,
as independent studies have verified that both activation
pathways can activate TRPC3 channels. A requirement for
src-mediated tyrosine phosphorylation of the Y226 channel
protein residue has recently been identified for opening TRPC3
channels [38,39].
Table 1
TRP expression in vascular tissues
Species TRPC TRPV TRPP TRPM Refs
1 2 3 4 5 6 7 1 2 3 4 2 1 2 3 4 5 6 7 8
Aorta (fresh and A7R5) R, M c a c c c c a c c a c c c a a a A [13,19,27,32,40,59,60,64,114,121,122]
Caudal artery R a a a [16]
Cerebral arteriole Rab a a a a a [13,123]
Cerebral artery M, H, R c a c c c c c c c a a [13,23,26,32,47,60,70,124–126]
Coronary artery H b b b b b [47,94,101]
Mesenteric artery M, R, F, Rab c a c a c a c c c [19,60,67,101,114,115]
Pulmonary artery R, H, M c a c c a c a c a a c c a a a c [14,17,18,28,33,41,42,49,51,52,59]
Renal artery R, C c c c c c a [27,52,127]
VECa M, H, R c c c c c c c [43,47,93,125,128,129]
PAEC H, R, B a a a c a a a a a a a a a a a a [28,45,48,49,92,107–109]
H, human; M, mouse; R, rat; Rab, rabbit; C, canine; B, bovine; F, frog; VEC, vascular endothelial cell; PAEC, pulmonary artery endothelial cell ‘a’, mRNA identified
only; ‘b’, protein identified only; ‘c’, both mRNA and protein identified.
a VECs correspond to endothelial cells from the middle cerebral arteriole, coronary and mesenteric artery, and aorta.
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TRPC5 and TRPC7. While TRPC4 is present in smooth muscle
[19,27,40–42], it is predominantly present in the endothelium
[43–48] where it plays an important role in regulating lung
microvascular permeability [44], agonist-dependent vasorelaxa-
tion [43], and gene transcription [45]. In SMC, TRPC4
expression and function may regulate CCE-mediated and
agonist-induced cell proliferation [41] and contraction [42].
Data describing TRPC5 expression in the pulmonary vascu-
lature are conflicting, with some studies showing ubiquitous
TRPC5 expression in PASMC and pulmonary artery endothelial
cells (PAEC) [49,50] and others showing mRNA but no protein
expression [42], or vice versa [51]. TRPC7 is not widely studied
in vascular tissues, although immunohistochemical analysis has
described its expression in coronary and cerebral artery
endothelial cells [47], as well as in aortic and renal artery
SMC [27,40,52]. TRPC7 is thought to contribute to both ROC
and SOC channel formation. It is possible that differential
subunit expression of TRPC7 alongside TRPC1, TRPC3 or
TRPC6 may confer the characteristic activity of either ROC or
SOC [40].
Several components or mechanisms are proposed to be
involved in SOC activation [20]: (i) linkage between TRPC1 and
IP3 receptors by the scaffolding protein Homer which is
regulated by the Ca2+ filling status of the SR [53], (ii)
involvement of stromal interaction molecule-1, which translo-
cates (after store depletion) from the SR to the plasma membrane
where it may be essential in TRP channel activation [54,55], and
(iii) release of a diffusible Ca2+ influx factor from the SR which
activates SOC via a Ca2+-independent phospholipase A2
mechanism [56]. Roles for agonist-bound IP3 receptors close
to the plasma membrane interacting with TRPC channels via
protein–protein reactions [57] and fusion of a Ca2+ entry
channel with the plasma membrane [58] are also proposed.
3.2. TRPM and TRPV
Published data on TRPM and TRPV subtypes in vascular
smooth muscle and endothelium are less abundant than that for
TRPC subunits. mRNA for TRPM2–4, TRPM7–8, andTRPV1–4 have been detected in both endothelium-denuded
rat aorta and pulmonary artery [12]. TRPM4, TRPM7, TRPV2,
and TRPV4 are currently the best characterized in the
vasculature. Gated by increased [Ca2+]i, TRPM4 is only
permeable to monovalent cations such as Na+ and K+ and
may contribute to myogenic vasoconstriction of cerebral
arteries [26]. The activity of TRPM7 is more closely related
to the regulation of Mg2+; Resting or agonist-induced [Ca2+]i
were unaffected by siRNA in aortic SMC, whereas the
permeability to Mg2+ was altered [59]. The impact of TRPM7
and intracellular Mg2+ regulation in the pulmonary vasculature
is still uncertain. Of the vanilloid receptors TRPV2 appears to
be involved in hypertonicity-activated cell swelling in aortic
SMC [60]. Yang et al. identified mRNA for TRPV1, TRPV2,
TRPV3 and TRPV4 in both PASMC and aortic SMC [59].
Finally, the polycystic disease 1-like and 2-like proteins (TRPP1
and 2) are expressed in vascular smooth muscle correlating to a
SOC-like channel [61].
4. TRP channels in agonist-mediated vascular contraction
and vascular SMC proliferation
TRP channels play an important functional role in the
regulation of vascular tone, being involved in agonist mediated
vascular contractility and mitogen-mediated smooth muscle cell
proliferation. Phenylephrine-induced contractions in the canine
pulmonary artery can be attributed to SOC being inhibited by
SK&F 96365 [62]. Interestingly, serotonin-induced pulmonary
vasoconstriction is attributed to ROC as it is insensitive to SOC
inhibitors and to store depletion by cyclopiazonic acid [63].
TRPC1 and TRPC6 are currently thought underlie ROC
responsible for agonist- and hypoxia-induced vasoconstriction
of pulmonary arteries [31,33] as well as in SMC from aorta
[64,65], portal vein [22,25,66], and mesenteric arteries [67].
One recent study, however, disputes the involvement of
TRPC6-encoded ROC channels in chronic hypoxia-induced
pulmonary hypertension [33]; TRPC6−/− mice exhibited no
significant changes in heart mass and pulmonary artery
muscularization in response to chronic hypoxia (compared to
their wild-type littermates). Conversely, expression of TRPC
Fig. 3. Potential mechanisms involved in ligand-mediated regulation of
intracellular [Ca2+]cyt through receptors, TRP channels, NCX1, and caveolin
colocalized within caveolae. Caveolin is a structural protein that not only
promotes the formation of caveolae, but also helps localize TRPC and NCX to
the plasma membrane of caveolae. The structure of caveolae also helps entrap
extracellular or intercellular ligands that activate the receptors and channels.
Because of the close proximity to each other and to ER/SR, the GPCR/RTK,
TRP channels, and NCX in the caveolae would significantly enhance the
agonist-mediated increase in [Ca2+]cyt.
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mechanism in these vascular tissues [16,18,42,49,68–73].
TRPM4 may function as a mechanosensor to promote pressure-
induced vasoconstriction in cerebral arteries [26] and TRPV4
may cause hypotonicity-induced airway contraction [74].
An intimate relationship between [Ca2+]i and cell prolifera-
tion exists and TRP channels may indeed be responsible for
increased Ca2+ influx stimulating proliferation. Indeed,
enhanced proliferation is associated with augmented CCE via
TRP-mediated SOC channels in PASMC [14,17,28,29,41,71].
5. Functional interaction of TRPs with the cytoskeleton and
within caveolae
The cytoskeleton and plasma membrane structures may play
an important role not only in TRP localization to the plasma
membrane, but also to TRP function itself. Caveolae are
cholesterol-rich compartments in the plasma membrane.
Caveolae function to centralize cooperative receptors, ion
channels, transporters, signalling moieties, and effectors within
plasma membrane microdomains [75] (Fig. 3). These regions
are important sites for ligand-mediated activation of receptors
and Ca2+ entry in both smooth muscle and, more prominently,
in endothelial cells [76,77] and are closely associated with the
endoplasmic or sarcoplasmic reticulum [78], as shown in Fig. 3.
Caveolin-1 (cav-1), the main structural protein in caveolae,
may play a crucial role in the plasma membrane localization of
both TRPC1 and TRPC3. Indeed, ET-1-induced vascular
contraction and TRPC1 co-localization with cav-1 are
decreased by caveolae disruption [16,79–81]. TRPC1 and
cav-1 have been proposed to physically interact. An N-terminal
cav-1 binding motif on the TRPC1 gene is involved in the
binding of cav-1, the regulation of TRPC1 plasma membrane
localization and the integrity of lipid rafts [82,83]. Indeed,
functioning of TRPC1 or capacitative Ca2+ entry is decreased
by cholesterol depletion [16,80], suggesting that TRPC function
is dependent upon the formation of caveolae. In addition, cav-1
may regulate both TRPC1 localization and function via
interaction with the caveolin-scaffolding domain, thereby
enhancing ER/SR-SOC channel interactions [82,84].
Other TRPC channels have also been implicated in having
functional co-localization with Ca2+ signalling pathways. For
example, TRPC4 has been shown to interact with a PDZ
domain on NHERF (Na+–H+ exchanger regulatory factor)
which makes interaction with PLC possible [85]. Remodelling
of the actin cytoskeleton enables coupling between IP3 type II
receptors and TRPC1 channels in platelets [86] and actin
stabilization prevents the internalization of TRPC3 channels
and loss of CCE [87,88]. Recently, Cioffi and co-workers
demonstrated that the activation of SOC channels in PAEC
necessitates the interaction of TRPC4 with cytoskeletal protein
4.1 [48].
Lately, Ca2+ entry via the reverse mode of the Na+/Ca2+
exchanger, which is functionally expressed in cultured human
PASMC, is suggested to contribute to store depletion-mediated
increases in [Ca2+]i [89] (Figs. 2 and 3). Potentially, blockade of
the reverse mode of the NCX could be a novel therapeuticapproach for treatment of pulmonary hypertension [89]. Rosker
and colleagues had previously shown that TRPC3 interacts with
the NCX providing a novel idea in TRP-NCX-mediated Ca2+
signalling [90]. Supporting data included (a) the extracellular
Na+ dependence of Ca2+ signals generated by TRPC3 over-
expression in HEK293 cells and (b) potent suppression of
TRPC3-mediated Ca2+ entry by inhibition of the NCX with
KB-R9743 [90]. Cell fractionation and co-immunoprecipitation
experiments demonstrated co-localization of TRPC3 and NCX1
in low density membrane fractions [90]. It is thus possible that,
as both TRPC3 and NCX expression are detected, this
signalling pathway is localized in caveolae (Fig. 3).
6. Differential physiological functions of TRP channels in
PASMC and PAEC
Interestingly, the expression of TRPs in smooth muscle and
endothelial cells may lead to different physiological effects. As
described above, TRP channel mediated Ca2+ influx in vascular
SMC causes vasoconstriction and also stimulates the prolifera-
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Ca2+ influx into EC stimulates the production of both
endothelium-derived relaxing (e.g., nitric oxide, prostacyclin)
and hyperpolarizing factors. By opening Ca2+-activated K+
channels, increased [Ca2+]i in EC also promotes K
+ efflux to the
intercellular space between EC and SMC, which induces
membrane hyperpolarization in SMC by activating inward
rectifier K+ channels [91]. All the processes ultimately lead to
EC-dependent vasodilation.
Several studies have demonstrated an important role for Ca2+
influx via SOC in vascular endothelial cells. In TRPC4−/− mice,
a strong correlation has been established between TRPC4, ATP-
and acetylcholine-induced Ca2+ influx, and relaxation in aortic
EC [44]; thrombin-induced Ca2+ influx was abolished in PAEC
isolated from TRPC4−/− mice [43,44]. Overexpression of
TRPC3 has been directly associated to increased Ca2+ influx
in response to ATP and bradykinin in PAEC [92]. Bradykinin
activates Ca2+ influx in mesenteric arterial EC which express
TRPC1 and TRPC3 channel mRNA [93]. TRPC1, especially, is
implicated in SOC function in PAEC [16,48].
Endocannabinoid-activated TRPV1 and TRPV4 channels
have been recently implicated in the control of vascular tone. In
mesenteric artery, endocannabinoid-mediated vasodilation may
also be regulated by these channels as the TRPV1-specific
inhibitor, capsazepine, reduced relaxation in response to
anandamide [94]. Furthermore, 2-arachidonoyl-glycerol acti-
vated TRPV1-mediated Ca2+ influx by phosphorylating
vasodilator-stimulated phosphoprotein (VASP) which may, in
turn, contribute to vascular relaxation by stimulating protein
kinases G and/or A [95].
Important functional roles for TRP isoforms in the regulation
of vascular permeability have also been proposed. Thrombin-
induced elevation of [Ca2+]i in EC activates pathways resulting
in endothelial cell contraction and disassembly of vascular
endothelial barriers, which subsequently increases vascular
permeability [96,97]. Permeability of the microvasculature of
the lung in response to hypoxia correlates with an increased
expression of TRPC4 and enhanced CCCE in PAEC [44,45].
Additional supporting evidence for the role of TRPC in
regulating pulmonary vascular permeability includes: (a)
TRPC4-dependent Ca2+ entry in mouse lung vascular EC
increases microvascular permeability [44,98]; (b) over-expres-
sion of TRPC1 augments, and anti TRPC1 antibody decreases,
thrombin- and VEGF-induced increases in vascular perme-
ability [99], and inhibition of TRPC1 by antisense oligonucleo-
tides reduces store-operated Ca2+ entry [100]; (c) VEGF-
mediated increase vascular permeability is mimicked by
TRPC6-activating agents OAG and flufenamic acid [101];
and (d) activation of TRPV1 by VASP is associated with
increased vascular permeability [95].
7. Upregulated TRP expression and/or function in
pulmonary and essential hypertension
Arterial pressure is a function of cardiac output and vascular
resistance. Hypertension occurs due to increased cardiac output
and/or elevated vascular resistance. In both the systemic andpulmonary vasculature, sustained vasoconstriction, obliteration
of small arteries due to physical occlusion of the vascular
lumen by thromboemboli, and severe vascular wall thickening
are the major underlying mechanisms for the increased
resistance to blood flow, and subsequently for the increased
arterial pressure. What follows is a discussion of how TRP
channels contribute to the onset and maintenance of pulmonary
and essential (systemic) hypertension.
7.1. Pulmonary hypertension
One of the hallmarks of severe PAH is pulmonary arterial
medial hypertrophy due to increased PASMC proliferation. TRP
channels, mainly those encoded by TRPC isoforms, have been
implicated in the development of pulmonary vascular medial
hypertrophy in PAH. TRPC3 and TRPC6mRNA and protein are
upregulated in PASMC from idiopathic PAH patients [30], and
subsequently enhanced Ca2+ influx through SOC/ROC may
partly account for the raised [Ca2+]i levels in PASMC from these
patients [17]. In addition to upregulation of TRPC3 and TRPC6,
the mRNA and protein expression of NCX1 and caveolin-1/2,
and the number of caveolae on the surface membrane are also
significantly increased in PASMC from idiopathic PAH patients
compared with cells from normal subjects and normotensive
patients with cardiopulmonary diseases [89,102].
As shown in Fig. 4, membrane receptors (G protein-coupled
receptors and receptor tyrosine kinases), TRP-encoded SOC/
ROC, and NCX are randomly distributed on the plasma
membrane in normal PASMC. However, in PASMC from
idiopathic PAH patients, the increased caveolin/caveolae may
render the upregulated TRP channels and NCX1 in close
proximity to receptors (or ligand-bound receptors), thereby
enhancing agonist- or mitogen-mediated Ca2+ influx through
TRP-formed ROC/SOC as well as inward Ca2+ transport via
reverse mode NCX1 (see Figs. 2 and 3). Furthermore, increased
caveolae and upregulated TRPC/NCX in caveolae may lead to
endocytosis or internalization by interacting with endocytic
proteins (e.g., clathrin, dynamin), TTP (SH3BP4, a SH3-
containing protein) [103], and receptor proteins. The endocy-
tosis of the ligand- and TRP/NCX-enriched caveolae would
make the internalized vesicles (which contain high [Ca2+])
more efficiently “reach” downstream Ca2+-sensitive targets
such as the SR/ER in the perinuclear area, compartmentalized
signalling protein complexes, nuclear envelope, mitochondria,
and contractile apparatus. The entrapped ligands and high
concentration of Ca2+ in the internalized caveolae/vesicles may
provide a sustained stimulation on receptors and cause a
massive rise in [Ca2+] in the “designated” area inside the cell
where Ca2+ is required for activating signal transduction
proteins and transcription factors. The internalized vesicles may
also play a role in efficiently and selectively raising [Ca2+] in
the nucleus, activating Ca2+-sensitive nuclear proteins and
transcription factors, and regulating gene transcription (Fig. 4).
With continuous activation of receptors on the plasma
membrane, cytoplasmic PLC-γ can bind to TRPC in the
internalized vesicles and increase channel insertion into the
plasma membrane [104,105]. Therefore, the upregulated TRP/
Fig. 4. Proposed mechanisms involved in the pathological role of upregulated TRPC and NCX as well as increased caveolin and caveolae in PASMC proliferation. In
comparison to normal PASMC, TRPC and NCX1 expression are upregulated and caveolin and caveolae are increased in PASMC from idiopathic PAH patients. The
increased number of the ligand- and TRP/NCX-enriched caveolae would not only enhance agonist-mediated increase in [Ca2+]cyt by enhancing receptor-mediated Ca
2+
influx through ROC and inward Ca2+ transportation through the reverse mode of NCX1, but also make the receptor/channel closer to intracellular organelles (e.g., the
ER/SR). The close proximity to the ER/SR would not only enhance receptor-mediated Ca2+ mobilization but also augment store depletion-mediated Ca2+ influx.
Furthermore, internalization or endocytosis of the ligand- and TRP/NCX-enriched caveolae (which contain 1.8 mM [Ca2+]) would make the high [Ca2+]-contained
vesicles be able to reach the ER/SR and mitochondria in the perinuclear area and the nuclear envelope and nucleus to provide Ca2+ for functional and transcriptional
needs. The dynamic cycling between the internalization and the re-insertion of TRPC/NCX in the caveolae or the cytoplasmic vesicles would serve as a potential
mechanism for initiating and maintaining sustained PASMC contraction, proliferation and migration.
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as well as the cycling between the internalization of ligand- and
TRPC/NCX-enriched caveolae and the re-insertion of vesicular
TRPC/NCX onto the plasma membrane would all contribute to
enhancing contraction, proliferation and migration in PASMC
from idiopathic PAH patients.
Similarly, TRPC1 and TRPC6 expressions are both enhanced
in normal PASMC treated with serum and growth factors [17] or
maintained in sustained hypoxia [31,72]. Inhibition of TRPC1
and TRPC6 using antisense oligonucleotides and TRPC6-
specific siRNA decreases SOC currents, inhibits Ca2+ influx,
reduces [Ca2+]i and inhibits PASMC proliferation [14,30].Wang
et al. demonstrated increased mRNA and protein expression of
TRPC1 and TRPC6 channels and enhanced capacitative Ca2+
entry via SOC in PASMC from rats and mice exposed to chronic
hypoxia, as well as in hypoxia-inducible factor-1 (HIF-1)-
transfected hypoxic PASMC [71]; HIF-1 is a transcription factor
known to contribute greatly to the progression of vascular
remodelling and hypoxic pulmonary hypertension [106].
Most of the discussion insofar has centered on the
physiological and pathogenic role of TRP in vascular smoothmuscle cells. However, as indicated in Table 1, TRP subunits
are also expressed in endothelial cells. As in PASMC, TRPC
channels' activation also raises [Ca2+]i through capacitative
Ca2+ entry via SOC and receptor-mediated Ca2+ entry through
ROC in PAEC. The end-effect may vary depending on the
origin of the PAEC. We previously reported that sustained
hypoxia increased activating protein-1 (AP-1) transcription
factor binding activity by enhancing Ca2+ influx via La3+-
sensitive TRPC4-encoded SOC channels in human PAEC [45].
In the same study, enhanced TRPC4 expression correlated with
increased SOC-dependent Ca2+ influx [45]. We thus speculated
that upregulated AP-1-responsive gene expression in PAEC
would result in increased generation of pro-proliferative or
vasoconstrictive products in PAEC (e.g., ET-1, PDGF, and
VEGF). These factors would then act on PASMC via paracrine
mechanisms to stimulate PASMC proliferation and, ultimately,
pulmonary vascular remodelling in patients with hypoxia-
mediated pulmonary hypertension.
An alternative theorem regarding the role of TRPC in PAEC
has also been proposed, centering on the role of PAEC as the
physical barrier between the lumen and PASMC. Disruption of
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formation of interendothelial gaps which allow circulating
vasoconstrictors and mitogens (e.g., serotonin, PDGF, throm-
bin) to penetrate into the vascular medial layer and act on newly
available PASMC. An increase in [Ca2+]i in PAEC underlies
their contraction; a number of studies have identified enhanced
SOC function as the cause for the increased [Ca2+]i in PAEC.
Some groups proposed that the increased expression of TRPC1
might underlie PAEC contraction and vascular endothelial
barrier dysfunction [107,108]. However, there is also evidence
to suggest that TRPC4 may also play a significant role in PAEC
contraction and regulating endothelial permeability. Tiruppathi
et al. demonstrated that TRPC4 knockout mice exhibit
decreased endothelial leakage and decreased SOC-mediated
CCE when stimulated with thrombin [44,98]. Alvarez et al.
[109] ‘proved’ both claims regarding TRPC1 and TRPC4 when
they showed that their downregulation may be involved in an
adaptive mechanism that limits endothelial permeability during
chronic heart failure.
7.2. Systemic hypertension
Although the alteration of cation influx channels has been
described in systemic hypertension, the precise underlying
mechanisms are still to be elucidated. A putative role for TRP
channel isoforms in the pathogenesis of pulmonary hyperten-
sion has been described above, however Liu et al. were among
the first to compare TRPC expression and function in
normotensive controls and spontaneously hypertensive rats
[110] and essential hypertension patients [111]. In monocytes
from hypertensive patients and rats, increased protein expres-
sion of TRPC3 and TRPC5 isoforms was associated with a
consequent increase of Ca2+ influx. This response was blocked
by SK&F 96365 and by knockdown of TRPC3 [110] and
TRPC5 [111] using targeted siRNA.
In addition to TRPC, other TRP isoforms may also be
implicated in systemic hypertension. Mg2+ is the second-most
prominent divalent cation in vascular smooth muscle cells, and
TRPM channels can regulate Mg2+ transport. Increased [Mg2+]i
can attenuate agonist-induced vasoconstriction [112]; vascular
SMC proliferation observed during hypertension may addition-
ally be regulated by extracellular Mg2+ [113]. In aortic and
mesenteric artery SMC, TRPM7 is upregulated by chronic
treatment with angiotensin II and aldosterone [114,115]. More
importantly, TRPM7-deficient cells do not proliferate in
response to angiotensin II. In a related study, TRPM7 was
found to be downregulated in mesenteric artery SMC from
spontaneously hypertensive rats compared to their normoten-
sive controls. The blunted expression of TRPM7 correlated with
a significantly decreased [Mg2+]i [115].
TRPV1 is found mainly in a family of primary afferent
capsaicin-sensitive sensory neurons which project to cardiovas-
cular and renal tissues [116]. It is also proposed to be involved in
the pathophysiology of salt-induced hypertension. TRPV1
expression and function appear to be linked to the ability to
compensate for salt-induced increases in blood pressure. More
specifically, TRPV1 is activated and its expression is upregu-lated during high salt intake in Dahl salt-resistant rats, thereby
acting to prevent salt-induced increases in blood pressure. In
contrast, TRPV1 expression and function are impaired in Dahl
salt-sensitive rats, rendering these animals sensitive to salt load
in terms of blood pressure regulation [117]. As added support for
this finding, Deng et al. demonstrated that activation of TRPV1
in hypertensive rats by rutaecarpine led to an increase in
calcitonin-gene related peptide (CGRP) release and a subsequent
decrease in blood pressure [118].
8. Genetic variations in TRP genes and their correlation
with pulmonary and essential hypertension
The discovery of specific genetic mutations predisposing to
both familial and idiopathic PAH may accelerate the under-
standing of the mechanisms in the pathogenesis of PAH. In
patients with idiopathic PAH, a C-to-G single-nucleotide
polymorphism (SNP) has been identified in the promoter
region (nt. −254) of TRPC6 gene; the allele frequency of the
−254(C→G) SNP is significantly higher in idiopathic PAH
patients than in normal subjects and patients with secondary
pulmonary hypertension [119]. Genotype analysis demon-
strated that 6.3% of idiopathic PAH patients carried homo-
zygous −254G/G, whereas none of the normal subjects did.
Moreover, the −254(C→G) SNP creates a binding sequence
for the transcription factor nuclear-factor-κB (NF-κB). Func-
tional analyses showed that the −254(C→G) SNP enhanced
NF-κB-mediated promoter activity and stimulated TRPC6
expression in PASMC. Inhibition of NF-κB attenuated TRPC6
expression in PASMC of idiopathic PAH patients harbour-
ing the −254G allele [119]. These results suggest that the
−254(C→G) SNP may predispose individuals to high-risk of
idiopathic PAH by upregulating TRPC6 expression in PASMC
and, additionally, by linking abnormal TRPC6 transcription in
PASMC to NF-κB, an inflammatory transcription factor [119].
Recently, monogenic human hypertension has been linked to
mutations in the gene coding for WNK4, a kinase of the WNK
family which regulates the expression of TRPV4. Fu and
colleagues have shown that co-expression of WNK4 down-
regulates TRPV4 function by decreasing its cell surface
expression in HEK-293 cells [120]. Collectively this study
demonstrates functional regulation of TRPV4 by WNK4 and
speculates that this pathway may impact systemic Ca2+ balance
[120].
9. TRP channels as potential therapeutic targets
Development of novel and effective therapeutic approaches
for patients with pulmonary hypertension and essential hyper-
tension is important. The functional correlation of TRP channel
expression with changes in blood pressure in both essential and
pulmonary hypertension highlights these channels as potential
therapeutic targets for the abrogation of vasoconstriction and
SMC proliferation characteristic of hypertensive disease states.
Indeed, bosentan, an endothelin receptor antagonist which is
currently approved by FDA for the treatment of PAH, has been
shown to inhibit ET-1- and PDGF-mediated PASMC growth in
Fig. 5. Role of TRP channels in the development of sustained vasoconstriction
and vascular remodelling in hypertension. Upregulated TRPC channels in
smooth muscle (and endothelial) cells would increase the activity of both ROC
and SOC cation channels and enhance Ca2+ influx when membrane receptors
are activated by circulating agonists and mitogens. The resultant increase in
[Ca2+]cyt triggers SMC contraction and stimulates SMC proliferation, and
ultimately causes sustained vasoconstriction and vascular wall thickening. Since
the vascular resistance is inversely proportional to the 4th power of the
intraluminal radius of arteries, a small decrease in radius as a result of
vasoconstriction and vascular wall thickening would significantly increase the
vascular resistance and ultimately increase the arterial pressure. In the systemic
vasculature, decreased function and expression of TRPV1 and TRPM channels
may contribute to causing SMC contraction by decreasing CGRP and cAMP in
sensory neurons and by decreasing cytoplasmic [Mg2+] in smooth muscle cells.
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expression [29]. New evidence also suggests that targeting of
other TRP isoforms may also prove beneficial in attenuating
essential hypertension in some models [118].
Therapeutic strategies should focus not only on inhibiting
TRP channel expression and function, but also on disrupting the
functional “partners” and microenvironment for TRP channels.
Therefore, agents should be developed which (a) inhibit TRP
channel trafficking and re-insertion; (b) disrupt functional and
physical coupling of TRP channels with membrane receptors
and transporters, intracellular organelles, and IP3 receptors; (c)
downregulate STIM/Orai-l or other messengers and intermedi-
ates that promote store depletion-mediated Ca2+; and (d) disrupt
caveolae by inhibiting cholesterol and caveolin production.
10. Conclusion
This review serves to highlight the importance of TRP
channels as integral pathogenic components and as potential
new drug targets to combat the detrimental effects of
vasoconstriction and vascular remodelling (due to SMC
proliferation) in hypertensive disease states (Fig. 5). In the
vasculature, several cation-permeable TRP channels have beenidentified as being involved in both the physiological and
pathophysiological regulation of vascular tone and smooth
muscle cell proliferation. In the pulmonary vasculature,
increased Ca2+ influx via store- and receptor-operated Ca2+
channels encoded by TRP genes may underlie both the
enhanced vascular medial hypertrophy as well as the endothelial
permeability which contributes to both pulmonary vascular
remodelling and pulmonary edema. In essential hypertension,
findings are not as clear, especially as it relates to non-TRPC
channel isoforms. What is apparent is that TRPC channel
upregulation is a strong promoter of vascular SMC proliferation
in both types of hypertension. The potential protective role of
TRPV and TRPM channels vis à vis blood pressure regulation
in essential hypertension provides us with a novel therapeutic
target in the treatment of hypertension.
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